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Abstract 
Abstract 
Review on der(9)t(1;9)(q11-12;q34), with data on 
clinics, and the genes involved. 
Clinics and pathology 
Disease 
Myeloid malignancies, multiple myeloma (MM) and 
plasma cell leukemia (PCL). 
Phenotype/cell stem origin 
3 patients were diagnosed with myeloid 
malignancies: 1 patient with acute myelomonocytic 
leukemia (Piccaluga et al., 2004), 1 with 
polycytemia vera (PV) (Andrieux et al 2003) and 1 
with chronic myelomonocytic leukemia (CMML) 
(Suh et al., 2009). There were 4 patients with MM 
(Smadja et al., 2001; Mohamedet al., 2007; Sawyer 
et al., 2014) and 1 case was diagnosed with plasma 
cell leukemia (Ueshima et al., 1983).  
6 additional cases were found with various 1q21-25 
and 9q34 breakpoints:  4 AML cases (Lai et al., 
1987; Smadja et al 1992; Raimondi et al., 1999; 
Yoshida et al., 2013), 1 Chronic myelogenous 
leukemia (CML) patient (Erdag et al., 2009) and 1 
patient withbiphenotypic leukemia (Matsuda et., al 
2009). (Table 1) 
leukemia.  
Epidemiology 
There was 7 male and 7 female patients (sex ratio 
1:1) aged 0 to 66 years including 2 infant patients, 
one of them with Down syndrome.  
Prognosis 




Presents as 2 normal chromosomes 1, one normal 
chromosome 9 and a der(9)t(1;9) chromosome, 
resulting in 1q trisomy associated with partial 
monosomy of 9q. 
Additional anomalies 
All the 3 reported patients with myeloid 
malignancies showed this translocation either as the 
sole abnormality (Piccaluga et al., 2004; Suh et al., 
2009) or as part of a simple karyotype (Andrieux et 
al., 2003). A complex karyotype was present in all 
MM patients, among them the 14q32 rearrangement 
was found as an accompanying anomaly in 3 out of 
4 patients (Smadja et al., 2001; Mohamed et al., 
2007; Sawyer et al., 2014). 




The unbalanced der(9)t(1;9)(q11-12;q34) is created 
by fusion in the centromeric region of 1q to a distant 
telomeric region of chromosome 9. It is a rare 
anomaly in patients with hematologic malignancies 
that results in trisomy of 1q associated with partial 
monosomy of 9q.  
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M MM 46-56,XY,+2,+3,+5,+6,del(6)(q23)x2,+7,+9,der(9)t(1;9)(q12;q34)x2,+11,+15,+17,+19,+mar 
3
. 









M/57 MM 44,XY,der(3)t(1;3)(q21;q29),t(4;14)(p16;q32),der(9)t(1;9)(q12;q34),-10,-13 
6
. 


















































Table 1. Reported patients with der(9)(q11-q12;q34) including additional cases with 1q21-q25 and 9q34 breakpoints. 
Abbreviations:  M, male; F, female; PCL, plasma cell leukemia; MM, multiple myeloma; PV, polycythemia vera; AML-M4, acute 
myelomonocytic  leukemia; CMML, chronic myelomonocytic leukemia; AML-M7, acute megakaryoblastic leukemia; CML, chronic 
myelomonocytic  leukemia; PBSCT, peripheral blood stem cell transplantation; BAL, bilineage or biphenotypic leukemia. 
1. Ueshima et al., 1983; 2-3. Smadja et al., 2001; 4. Andrieux et al., 2003;  5. Piccaluga et al., 2004; 6. Mohamed et al 2007; 7. 
Suh et al., 2009; 8. Sawyer et al 2014; 9. Lai et al 1987; 10. Smadja et al 1992; 11. Raimondi et al., 1999;  12. Erdag et al 2009; 
13. Matsuda et al 2009; 14. Yoshida et al 2013. 
 
The formation of an extra copy of the entire 1q 
suggest that trisomy of genes located on 1q, rather 
than partial 9q monosomy is involved in disease 
pathogenesis. This is further supported by the 
occurrence of additional cases of der(9)t(1;9) with 
various 1q21-25 breakpoints, suggesting that altered 
gene dosages in a part or the entire long arm of 
chromosome 1 may be important for disease 
initiation or progression. 
Alternatively, the breakpoint at 9q34, where the 
ABL1 gene is located rises the possibility of its 
involvement in the translocation, at least in some 
patients.  
However, the absence of ABL1 rearrangement or the 
BCR / ABL1 fusion gene was excluded only in 
sporadic cases (Piccaluga et al., 2004; Suh et al., 
2009).  
Because of the rare occurrence, further studies are 
needed to evaluate the genes involved in the 
oncogenesis as well as the suggested association of 
this rearrangement with monocytic-lineage leukemia 
(Suh et al., 2009). 
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